3D Medicines, Inc. (HK:1244) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
3D Medicines Inc. has officially adopted a Chinese name for dual foreign name representation and announced that a new Chinese stock short name will be effective for trading on the Stock Exchange from August 5, 2024. This change is not expected to affect shareholder rights or the company’s operations and finances, and current share certificates will remain valid.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.